… several important cellular mechanisms and may contribute to neurodegeneration. To recover GCase activity, we propose to use small molecules called non-competitive pharmacological chaperones that specifically … results will be further tested in models of PD/GBA with the goal to ease PD symptoms and pathology. The final …

… Michael J. Fox Foundation (MJFF) announces 69 grants that total $60.6 million awarded in April and May 2025.  These … the gap between discovery research and clinical trials with the Therapeutics Pipeline Program . The program ensures … targeting mitochondria.  More PPMI-driven research is coming, including from MJFF’s new PPMI Biofluid Biomarkers …

… Editor's Note: Stay tuned for an MJFF News in context about … said Dr. Stanley Appel, a Texas researcher who is familiar with the UNMC work. A vaccine developed by UNMC researchers … neurons. The result is that the disease becomes worse. Injection of the vaccine produced cells that …

… Michael J. Fox Foundation (MJFF) announces 129 grants that total more than $40.2 million awarded in August and … PD 20 years ago, and they are now understood to be the most common causes of inherited PD. The mutations typically … drug to reduce LRRK2 activity using a less-studied approach with the hope that it retains beneficial effects while …

… Ever wonder what it would be like to ride a real Hoverboard, just like Michael did in Back to the Future II ? While we may never have the technology to … (EST) so make sure you head over to www.hoverboardauction.com to get your bids in now! Sam Fox …

… run of the entire Pacific Crest Trail in 2011 and his Hamptons Hundred Miler run this past July. Running for Team Fox … touched by the disease to share their personal experience with others. As an added incentive, biopharmaceutical company UCB, Inc. will donate $5, up to $60,000 to MJFF for …